Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Moderna Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)

Monday, November 30, 2020

Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines to create a new generation of transformative medicines for patients announced a supply agreement with the UK government for an additional million doses of mR...

Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders

Friday, November 27, 2020

Biogen Incand Sage Therapeutics Inc announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone SAGE for major depressive disorder MDD postpartum depression PPD and other psychiatric...

Egle Therapeutics Identifies First Novel Regulatory T-cell Targets in Research Alliance with Takeda

Friday, November 27, 2020

Egle Therapeutics SAS Egle an emerging biotechnology company focused on developing firstin class immunotherapies targeting immune suppressor regulatory Tcells Tregs for oncology and autoimmune diseases today announces that it has achieved the first m...

BioInvent and Cantargia sign manufacturing agreement for monoclonal antibody CAN10

Thursday, November 26, 2020

Cantargia AB and BioInvent International AB announced that BioInvent has been contracted as manufacturer of Cantargias antibody CAN in preclinical development for the treatment of systemic sclerosis and myocarditis CAN is fully humanized monoclonal a...

RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of Opaganib for COVID-19

Thursday, November 26, 2020

RedHill Biopharma Ltd a specialty biopharmaceutical company today announced partnerships with two leading USbased manufacturers for largescale manufacturing of opaganib These collaborations further advance ongoing preparations to support potential em...

QuadraMuneâ„¢ Synergizes with Metformin to Stimulate Anti-Viral Defenses in Pilot Clinical Trial

Wednesday, November 25, 2020

Therapeutics Solution International Inc reported today clinical trial data demonstrating significant increases in natural killer cell activity in healthy volunteers receiving daily QuadraMune as compared to controls taking placebo Using a standard t...

OncoSec Announces Exclusive License Agreement for Cliniporator® Gene Electrotransfer Platform Developed by IGEA Clinical Biophysics

Wednesday, November 25, 2020

OncoSec Medical Incorporated a latestage biotechnology company developing intratumoral cancer immunotherapies today announced that it has licensed the exclusive rights to the Cliniporator electroporation or gene electrotransfer platform from IGEA Cli...

HiFiBiO Therapeutics Inks Partnership with Pharmsynthez and IBCh for the Clinical Development and Commercialization of its SARS-CoV-2 Neutralizing Antibody in Russia

Tuesday, November 24, 2020

Horizon Therapeutics plc and Halozyme Therapeutics Inc announced a global collaboration and license agreement that gives Horizon exclusive access to Halozymes ENHANZE drug delivery technology for subcutaneous SC formulation of medicines targeting IGF...

Novellus and Tempus Announce Collaboration to Accelerate Clinical Trial Patient Enrollment

Tuesday, November 24, 2020

Novellus Ltd a clinicalstage biotechnology company focused on precision oncology and Tempus a leader in artificial intelligence and precision medicine announced their collaboration to accelerate patient enrollment for Novellus next generation BRAF in...

RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease

Monday, November 23, 2020

RedHill Biopharma Ltd a specialty biopharmaceutical company announced that it has initiated its Phase study to evaluate the safety and efficacy of RHB as a potential firstline standalone oral treatment of pulmonary nontuberculous mycobacteria NTM di...

Latest Issue
Get instant
access to our latest e-book